Webinar Tomorrow: Decreasing Costs in your Sterile Compounding Operation without Sacrificing Quality

There is a tremendous amount of pressure on pharmacy leadership to cut operating costs in their departments and many compliance elements of USP 797 are viewed as expensive and ripe for replacing or ripping out. Eric S. Kastango, MBA, RPh, FASHP will provide the attendees with actionable ideas that will improve the efficiency of your sterile compounding operation which will result in decreased costs without sacrificing quality.

Wednesday, May 9, 2012 1:00 PM – 2:00 PM EDT

Click here to register for the webinar.

Advertisements

Eric Kastango’s webinar: “Understanding USP 71 Sterility Tests and Extended BUD”

Eric Kastango just did a webinar on Wednesday titled “Understanding USP 71 Sterility Tests and Extended BUD.” You can view an archive of the webinar at http://rph.com/webinars/.

Excellent Blog about Pharmacy Operations

I know its been a while since I posted last… summer is finally kicking into gear here in Seattle and life seems to get so much busier! I just got back from a camping trip with my wife and 3 daughters. But you’re not here to read about my personal life…

I highly recommend you check out the Community Forum that Pharmacy OneSource has recently started. Among other topics, it has a great section on Pharmacy Operations that includes lots of Q&A about USP 797, and usually the answers come directly from Eric Kastango. Check the forums here.

California Compounding Regulations FAQs Being Sought

Just received this email from the California State Board of Pharmacy:

Compounding Regulations FAQs Are Being Sought

The California State Board of Pharmacy announces that at its Enforcement Committee Meeting  on June 16 in Sacramento,  a question and answer session will be held to discuss the Board’s Implementation of 16 California Code of Regulations Sections 1735-1735.8, Pharmacies That Compound, and Sections 1751-1751.8, Pharmacies That Compound Sterile Injectable Medications.  These requirements will go into effect on July 6, 2010.

Questions for the Board’s Enforcement Committee to answer about the compounding regulations may be submitted in advance to Susan.Williams@dca.ca.gov.  Questions and anwers developed will be posted on the board’s Web site in the future, so those individuals submitting questions do not need to attend the meeting.  Not every question submitted may be answered by the committee.

Please click on this link to view the Enforcement Committee Meeting agenda:

http://www.pharmacy.ca.gov/meetings/agendas/2010/10_jun_enf.pdf

22% of Hospitals Currently Meet USP 797 Regulations

From Pharmacy Purchasing & Products annual State of Pharmacy Compounding Survey for 2010 based on 322 pharmacy director responses:

  • 22%   Meet/exceed all requirements
  • 56%   Meet most requirements
  • 15%   Meet some requirements
  • 4%    Plan to address
  • 3%    No plan for compliance

With less than a quarter of pharmacies currently fully compliant, here is the projected timeline to compliance for those not there yet:

  • 31%   Within 6 months
  • 32%  6 months – 1 year
  • 23%  1-2 years
  • 5%    2-3 years
  • 9%   No plans for compliance

What if your loved one was the recipient of the next CSP you make?

Would you do anything differently if you knew that the next CSP you are preparing was for your mother or your child? Eric Kastango recommends that the the “Loved-one Rule” be part of your training program:

Any compliance approach should integrate the ‘loved-one’ rule, where staff are asked to picture loved ones as the recipient of the final CSPs, making the patients they may never meet more real.

53% Expect Compounding Volume to Rise: 2010 State of Pharmacy Compounding Survey

From Pharmacy Purchasing & Products annual State of Pharmacy Compounding Survey for 2010 based on 322 pharmacy director responses:

Current Daily Compounding Volume (by Number of CSP’s):

  • 1-50 CSPs: 36%
  • 51-100 CSPs: 21%
  • 101-200 CSPs: 13%
  • 201-500 CSPs: 12%

Future Compounding Volume:

  • Increase: 53%
  • Stay the Same: 35%
  • Decrease: 12%

I was hoping to compares these data to last year, but it was presented in a different format that would have a made it very difficult without having the underlying data. I actually prefer the way they presented it last year, broken down by bedsize.